Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beyond BRIC: 'Pharmerging' Markets Loom If Pharma Is To Expand, IMS Study Says

This article was originally published in PharmAsia News

Executive Summary

Drug makers need to more aggressively target so-called "pharmerging" markets - but not just the usual suspects. Brazil, Russia, India and China remain highly important, but in a March 16 report, IMS Health predicts that 17 countries, in total, will contribute 48 percent of annual market growth in 2013, up from 37 percent last year

You may also be interested in...



Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine

An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry

Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine

An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry

Vietnam Drug Authority Plan To Develop Local Drug Industry Is Mixed Bag For Foreign Drug Makers

The Vietnam Drug Administration has drafted a new master plan for developing its local drug industry that envisions supplying a majority of the country's demand for drugs from local drug makers by 2020-30

Related Content

UsernamePublicRestriction

Register

SC074290

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel